海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Phase II study of pembrolizumab in advanced hepatocellular carcinoma as second-line treatment after failure of sorafenib: integration of genomic analysis to identify predictive molecular subtypes
- ;Neoplasms
- Korea, Republic of
- 2018-10-25
Recruiting
- Efficacy and safety of apatinib mesylate in the treatment of recurrent uterine malignancies with failure of second-line and above chemotherapy
- Malignant uterine tumor
- China
- 2018-10-19
Recruiting
- Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma
- Lung Carcinoma
- China
- 2018-10-11
Not recruiting
- Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
- Gestational Trophoblastic Neoplasia
- China
- 2018-10-02
Not recruiting
- The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women
- PYY;Ghrelin;Appetite;Gut Hormones;Obesity;Protein Consumption
- Indonesia
- 2018-10-02
Recruiting
- An exploration of Apatinib Plus IP solution as 2nd Line Treatment in Patients With Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- China
- 2018-09-30
Not recruiting
- Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC
- Lung Cancer;Lung Cancer Metastatic
- China
- 2018-09-19
Recruiting
- Cardiovascular Risk Comparison between Expanded Hemodialysis using Theranova and On-line Hemodiafiltration
- ;Diseases of The genitoruinary system
- Korea, Republic of
- 2018-09-19
Not Recruiting
- Clinical study for exemestane with metronomic capecitabine in the second-line treatment of metastatic breast cancer
- breast cancer
- China
- 2018-09-17
Recruiting
- A Phase II study for the SOXIRI protocol in the first-line treatment of non-surgical resection or metastatic pancreatic cancer
- pancreatic cancer
- China
- 2018-09-06
Recruiting
- Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus
- Type 2 Diabetes Mellitus;PreDiabetes
- Malaysia
- 2018-08-29
Recruiting
- Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- China
- 2018-08-23
Recruiting
- Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer
- Effectiveness and Safety for Real World Study on Crizotinib Used for ROS1 Arranged Non-squamous Non-small Cell Lung Cancer
- China
- 2018-08-23
Recruiting
- First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases
- Non-small Cell Lung Cancer;EGFR Gene Mutation;Brain Metastases
- China, Korea, Republic of, Singapore, Taiwan
- 2018-08-22
Not Recruiting
- A single-arm, prospective Clinical Study of apatinib combined with SOX protocol for first-line treatment of advanced gastric cancer
- not operable, recurrent or metastatic advanced gastric or gastric esophageal junction adenocarcinoma
- China
- 2018-08-17
Recruiting
- First-line chemotherapy combined with or without apatinib in patients with primary recurrence of cervical cancer
- CERVICAL CANCER
- China
- 2018-08-17
Not Recruiting
- Monoeffect or combinative effect and their mechanism of HSF1 and P53 on the sensitivity of pancreatic cancer treated by 125I radiotherapy
- pancreatic cancer
- China
- 2018-08-15
Recruiting
- Anlotinib-based combination as first-line treatment in advanced non-small cell lung cancer: a single center, three arms and exploratory study
- lung cancer
- China
- 2018-08-08
Not Recruiting
- Clinical study for anlotinib monotherapy and anlotinib combined with vinorelbine in the second-line treatment of advanced lung squamous cell carcinoma
- Squamous Cell Lung Cancer
- China
- 2018-08-06
Recruiting
- Phase II Study of Anlotinib as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- China
- 2018-08-05